Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - October 2002

  1. Progress Toward Poliomyelitis Eradication--Angola, January 1998-June 2002 MMWR Morb.Mortal.Wkly.Rep.  8-30-2002, 51 (34): 762-764. 
  1. Immunization Registry Progress--United States, 2002 MMWR Morb.Mortal.Wkly.Rep.  8-30-2002, 51 (34): 760-762. 
  1. Outbreak of Measles--Venezuela and Colombia, 2001-2002 MMWR Morb.Mortal.Wkly.Rep.  8-30-2002, 51 (34): 757-760. 
  1. Ahmad, K.  Vaccination With Varicella Protects Against Zoster Infection Lancet Oncol.  2002, 3 (9): 523. 
  1. Arthur, A. J., Matthews, R. J., Jagger, C., Clarke, M., Hipkin, A., and Bennison, D. P.  Improving Uptake of Influenza Vaccination Among Older People: a Randomised Controlled Trial Br.J.Gen.Pract.  2002, 52 (482): 717-2. 
  1. Buschard, K. and Funda, D.  Vaccination Studies in Type 1 Diabetes Lancet  8-10-2002, 360 (9331): 488. 
  1. Carabin, H., John, Edmunds W., Kou, U., Van Den, Hof S., and Hung, Nguyen, V  The Average Cost of Measles Cases and Adverse Events Following Vaccination in Industrialised Countries BMC.Public Health  2002, 19;2 (1): 22. 
  1. Chen, M., Hu, K. F., Rozell, B., Orvell, C., Morein, B., and Liljestrom, P.  Vaccination With Recombinant Alphavirus or Immune-Stimulating Complex Antigen Against Respiratory Syncytial Virus J.Immunol.  9-15-2002, 169 (6): 3208-3216. 
  1. Choudhri, Y., Walop, W., Squires, S., Tam, T., King, A., Skowronski, D., Warrington, R., and Wood, J.  ORS During the 2000-2001 Influenza Vaccination Season Can.Commun.Dis.Rep.  9-1-2002, 28:2-8: 2-8. 
  1. Eichner, M., Diebner, H. H., Schubert, C., Kreth, H. W., and Dietz, K.   Estimation of the Time-Dependent Vaccine Efficacy From a Measles Epidemic Stat.Med.  8-30-2002, 21 (16): 2355-2368. 
  1. Engler, R. J., Kenner, J., and Leung, D. Y.  Smallpox Vaccination: Risk Considerations for Patients With Atopic Dermatitis J.Allergy Clin.Immunol.  2002, 110 (3): 357-365. 
  1. Hopkins, Tanne J.  Old Smallpox Vaccination May Still Protect BMJ  9-7-2002, 325 (7363): 513. 
  1. Huo, Z., Miles, J., Harris, T., and Riches, P.  Effect of Pneumovax((R)) II Vaccination in High-Risk Individuals on Specific Antibody and Opsonic Capacity Against Specific and Non-Specific Antigen Vaccine  10-4-2002, 20 (29-30): 3532. 
  1. Husain, S., Slobodkin, D., and Weinstein, R. A.  Pneumococcal Vaccination: Analysis of Opportunities in an Inner-City Hospital Arch.Intern.Med.  9-23-2002, 162 (17): 1961-1965. 
  1. Jackson, L. A., Yu, O., Heckbert, S. R., Slobodkin, D., and Weinstein, B. M., Malais, D., Barlow, W. E., and Thompson, W. W.  Influenza Vaccination Is Not Associated With a Reduction in the Risk of Recurrent Coronary Events Am.J.Epidemiol.  10-1-2002, 156 (7): 634-640. 
  1. Mixeu, M. A., Vespa, G. N., Forleo-Neto, E., Toniolo-Neto, J., and Alves, P. M.   Impact of Influenza Vaccination on Civilian Aircrew Illness and Absenteeism Aviat.Space Environ.Med.  2002, 73 (9): 876-880. 
  1. O'Reilly, D., Gormley, G., Gilliland, A., Cuene-Grandidier, H., Rafferty, C., Reilly, P., Steele, K., Stevenson, M., and Smyth, B.  Influenza Vaccinations in Northern Ireland: Are Older Patients Missing Out? Age Ageing  2002, 31 (5): 385-390. 
  1. Orr, P.  Supplementary Statement for the 2002-2003 Influenza Season: Update on Oculo-Respiratory Syndrome in Association With Influenza Vaccination Can.Commun.Dis.Rep.  9-1-2002, 28:1: 1. 
  1. Perez-Trallero, E., Vicente, D., Montes, M., and Cisterna, R.  Positive Effect of Meningococcal C Vaccination on Serogroup Replacement in Neisseria Meningitidis Lancet  9-21-2002, 360 (9337): 953. 
  1. Petousis-Harris, H.  Needle Angle When Giving i.m. Vaccinations Nurs.Prax.N.Z.  2002, 18 (2): 52-53. 
  1. Pfahlberg, A., Botev, I. N., Kolmel, K. F., and Gefeller, O.  Vaccination and Melanoma Risk Int.J.Cancer  11-1-2002, 102 (1): 96-97. 
  1. Pfahlberg, A., Kolmel, K. F., Grange, J. M., Mastrangelo, G., Krone, B., Botev, I. N., Niin, M., Seebacher, C., Lambert, D., Shafir, R., Schneider, D., Kokoschka, E. M., Kleeberg, U. R., Uter, W., and Gefeller, O.  Inverse Association Between Melanoma and Previous Vaccinations Against Tuberculosis and Smallpox: Results of the FEBIM Study J.Invest Dermatol.  2002, 119 (3): 570-575. 
  1. Rayner, J. O., Dryga, S. A., and Kamrud, K. I.  Alphavirus Vectors and Vaccination Rev.Med.Virol.  2002, 12 (5): 279-296. 
  1. Razum, O.  Editorial: A Farewell to Polio Vaccination? Not Anytime Soon Trop.Med.Int.Health  2002, 7 (10): 811-812. 
  1. Ring, A., Marx, G., Steer, C., and Harper, P.  Influenza Vaccination and Chemotherapy: a Shot in the Dark? Support.Care Cancer  2002, 10 (6): 462-465. 
  1. Roche, P. and Spencer, J.  Polio Eradication in Australia and the World Commun.Dis.Intell.  2002, 26 (2): 113-117. 
  1. Shlush, L. I., Behar, D. M., Zelazny, A., Keller, N., Lupski, J. R., Beaudet, A. L., and Bercovich, D.   Molecular Epidemiological Analysis of the Changing Nature of a Meningococcal Outbreak Following a Vaccination Campaign J.Clin.Microbiol.  2002, 40 (10): 3565-3571. 
  1. Siedler, A., Hermann, M., Schmitt, H. J., and Von Kries, R.  Consequences of Delayed Measles Vaccination in Germany Pediatr.Infect.Dis.J.  2002, 21 (9): 826-830. 
  1. Vazquez, J. A.  [Development of Vaccinations Against Meningococcus: a Long, Winding, and Still Unfinished Road] Enferm.Infecc.Microbiol.Clin.  2002, 20 (7): 313-315. 
  1. Vidyashankar, C.  Optimal Age for Measles Vaccination J.Indian Med.Assoc.  2002, 100 (1): 24-26. 
  1. Yazbak, F. and Yazbak, K.  Live Virus Vaccination Near a Pregnancy: Flawed Policies, Tragic Results Med.Hypotheses  2002, 59 (3): 283.

Back to Top